Pharma channel feed

Why the Supreme Court's over­rule of Chevron has ma­jor im­pli­ca­tions for the FDA

10 months ago
FDA+
Law

In­side BAR­DA's multi­bil­lion-dol­lar ef­fort to fund long-shot biotechs for Covid

10 months ago
Coronavirus

Rovi teas­es ac­qui­si­tion of­fers for its CD­MO unit po­ten­tial­ly worth €2B to €3B

10 months ago
Deals
Manufacturing

Lykos takes an­oth­er hit as ICER lays out 'in­suf­fi­cien­t' ev­i­dence for MD­MA-based treat­ment

10 months ago
R&D

House pan­el ad­vances bill to al­low Medicare to cov­er obe­si­ty drugs

10 months ago
FDA+

What Co­herus' $40M sale of its Hu­mi­ra biosim­i­lar says about the crowd­ed mar­ket

10 months ago
Deals

Supreme Court nar­row­ly re­jects Pur­due bank­rupt­cy plan, says it gives Sack­lers too much pro­tec­tion

10 months ago
Law

Grail pi­o­neered mul­ti-can­cer tests. But the com­pa­ny’s rough pub­lic de­but shows the in­dus­try could be in trou­ble

10 months ago
Diagnostics

Ab­b­Vie buys Third Rock­'s Cel­sius for $250M to ex­pand IBD pipeline

10 months ago
Deals

Ab­b­Vie and Gen­mab score ac­cel­er­at­ed fol­lic­u­lar lym­phoma nod for Ep­kin­ly 

10 months ago
FDA+

FDA re­jects Dai­ichi Sanky­o's HER3 ADC, a blow to quick ap­proval plans for Mer­ck part­ner­ship

10 months ago
R&D
FDA+

FDA ap­proves new COPD drug from Verona Phar­ma

10 months ago
FDA+

Up­dat­ed: CDC ex­pands RSV vac­cine rec­om­men­da­tions, name­ly for adults 75 and old­er

10 months ago
FDA+

Ha­le­on to sell nico­tine re­place­ment ther­a­py busi­ness to Dr. Red­dy’s for $630M

10 months ago
Deals

Op­tum Rx may en­ter biosim­i­lar mar­ket to match com­peti­tors CVS, Ex­press Scripts

10 months ago

HHS re­veals 64 drugs up for Medicare in­fla­tion re­bates next quar­ter

10 months ago
FDA+

EMA calls for mem­ber states to lend a hand to ease GLP-1 sup­ply bot­tle­necks

10 months ago
Manufacturing

No­vo Nordisk takes $816M write­down af­ter Phase 3 fail in chron­ic kid­ney dis­ease

10 months ago
R&D

Mod­er­na's up­dat­ed RSV vac­cine dis­ap­points with on­ly 50% ef­fi­ca­cy

10 months ago
R&D

Ar­row­head shelves one car­diometa­bol­ic drug can­di­date, fo­cus­es on an­oth­er

10 months ago
R&D

Lil­ly be­comes the lat­est phar­ma to tap Ope­nAI for help, this time for an­tibi­ot­ic work

10 months ago
R&D
AI

Q&A: FDA med­ical pol­i­cy chief talks de­cen­tral­ized tri­al guid­ance, im­prov­ing di­ver­si­ty

10 months ago
FDA+

Am­gen calls Col­orado's price con­trols on En­brel 'un­con­sti­tu­tion­al'

10 months ago
Law

Te­va to pay $750M to re­solve Is­rael tax dis­putes

10 months ago
Law
First page Previous page 46474849505152 Next page Last page
A service from the Financial Times